The Effect of Oxygen Therapy on Atelectasis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-05-01

Study Completion Date

2022-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In pregnancy, cephalal shift of the diaphragm caused by the enlarged uterus reduces the functional residual capacity and may increase the closure volume and predispose the pregnant woman to airway closure, leading to atelectasis. The development of atelectasis due to dermatomes retained in spinal anesthesia and intraoperative supine position may increase further. Oxygen therapy to be applied may also lead to absorption atelectasis by causing hyperoxia. The aim of our study is to evaluate the effect of oxygen support on the lungs in cesarean section operations under spinal anesthesia by lung ultrasound score and oxygen reserve index.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Atelectasis During Delivery - Comparing Cesarian (c) -Section and Labor

NCT00665405

Delivery, Obstetric Cesarean Section Labor +2 more

COMPLETED

Effects of Anesthesia on Atelectasis

NCT06790901

Atelectasis General Aneshesia

COMPLETED

Diagnostic Values of Lung Ultrasound for Perioperative Atelectasis

NCT02355405

Postoperative Pulmonary Atelectasis

COMPLETED

Supine vs Prone Position and Atelectasis Assessed by Lung Ultrasound

NCT07320092

Postoperative Atelectasis

RECRUITING

Which Ventilatory Strategy is Better for Lung in Upper Abdominal Surgeries?

NCT04872361

Anesthesia Induced Atelectasis

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atelectasis Cesarean Section Hypotension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group 0

control group

lung ultrasound score

Intervention Type DIAGNOSTIC_TEST

determination of atelectasis by lung ultrasound score

group 3

3 Lt/min Oxygen therapy via nasal cannula

lung ultrasound score

Intervention Type DIAGNOSTIC_TEST

determination of atelectasis by lung ultrasound score

group 6

6 Lt/min Oxygen therapy via Simple face mask

lung ultrasound score

Intervention Type DIAGNOSTIC_TEST

determination of atelectasis by lung ultrasound score

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

lung ultrasound score

determination of atelectasis by lung ultrasound score

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-50 years old
* ASA I-II
* Patients scheduled for elective cesarean section under spinal anesthesia

Exclusion Criteria

* alcohol or drug addiction, chronic obstructive pulmonary disease, cardiovascular disease, smokers anemia, liver or kidney disease, coagulation disorders allergic to anesthetic agents, sepsis or bacterial infection, body temperature is below 35°C and above 38°C Multiple pregnancy Preoperative hypoxemia SpO2\<94% Diabetes mellitus Hypertension Placenta previa Premature rupture of membranes Intrauterine growth retardation Preeclampsia-eclampsia-fetal distress Polyhydramnios Morbid obesity BMI\>45

Minimum Eligible Age

18 Years

Maximum Eligible Age

47 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes